CLI:MILCentrale del Latte d'Italia S.p.A. Analysis
Data as of 2026-06-09 - not real-time
€4.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Centrale del Latte d'Italia trades at €4.20, just above its 20‑day SMA (≈4.14) but below the 50‑day and 200‑day averages, placing it in a neutral technical zone. The RSI hovers around 49, indicating no clear overbought or oversold condition, while the MACD histogram turned positive, giving a modest bullish signal as volume continues to rise. Valuation metrics show a price‑to‑book of 0.74 and a forward P/E near 6, both suggesting the stock is priced well below its book value and expected earnings, a classic value opportunity.
The latest interim results reveal a 1.2% dip in revenue to €77.1 million, yet EBITDA climbed 4% to €7.1 million, lifting the EBITDA margin to 9.2%. Conversely, net profit fell sharply (‑19.8%), reflecting pressure on commercial costs and a thin trailing profit margin of just over 1%. The balance sheet is leveraged, with debt exceeding equity by more than 120%, but the company holds €70 million in cash, providing a modest cushion.
Risk factors include high 30‑day volatility (≈27%) and very low trading liquidity (average daily volume under 4,000 shares for a €55 million market cap). Beta is low, indicating limited market‑wide price swings, and the consumer‑defensive sector generally offers stability, though regulatory and geographic exposures remain medium. Given the undervalued pricing, improving EBITDA, and defensive industry backdrop, a cautious buy stance is warranted for the medium term, while short‑term positioning should remain on hold pending confirmation of a breakout above the €4.38 resistance.
The latest interim results reveal a 1.2% dip in revenue to €77.1 million, yet EBITDA climbed 4% to €7.1 million, lifting the EBITDA margin to 9.2%. Conversely, net profit fell sharply (‑19.8%), reflecting pressure on commercial costs and a thin trailing profit margin of just over 1%. The balance sheet is leveraged, with debt exceeding equity by more than 120%, but the company holds €70 million in cash, providing a modest cushion.
Risk factors include high 30‑day volatility (≈27%) and very low trading liquidity (average daily volume under 4,000 shares for a €55 million market cap). Beta is low, indicating limited market‑wide price swings, and the consumer‑defensive sector generally offers stability, though regulatory and geographic exposures remain medium. Given the undervalued pricing, improving EBITDA, and defensive industry backdrop, a cautious buy stance is warranted for the medium term, while short‑term positioning should remain on hold pending confirmation of a breakout above the €4.38 resistance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support level with modest bullish MACD
- High short‑term volatility and low liquidity
- Neutral RSI and mixed earnings signal
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued price‑to‑book and forward P/E
- EBITDA margin expansion and improving forward EPS
- Defensive consumer sector offering stable demand
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Elevated debt‑to‑equity ratio limiting financial flexibility
- Low ROE and thin profit margins
- Long‑term industry stability but modest growth outlook
Key Metrics & Analysis
Financial Health
Revenue Growth-1.20%
Profit Margin1.18%
P/E Ratio14.5
ROE5.65%
ROA2.25%
Debt/Equity123.92
P/B Ratio0.7
Op. Cash Flow€25.0M
Free Cash Flow€18.9M
Technical Analysis
TrendNeutral
RSI49.2
Support€4.01
Resistance€4.38
MA 20€4.14
MA 50€4.32
MA 200€4.32
MACDBullish
VolumeIncreasing
Fear & Greed Index87.64
Valuation
Fair Value€16.88
Target Price€6.00
Upside/Downside42.86%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.16
Volatility26.56%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.